Calreticulin Mutation in JAK2V617F Negative Myeloproliferative Neoplasms - The Beaumont Experience

被引：0
|
作者：
Sikdar, Soma [1 ]
Prada, Anne [1 ]
Crisan, Domnita [1 ]
机构：
[1] William Beaumont Hosp, Royal Oak, MI 48072 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1505
引用
收藏
页码：378A / 378A
页数：1
相关论文
共 50 条
  • [31] JAK2V617F mutation detection in myeloproliferative disorders (MPD)
    Bakkus, M. H. C.
    Trullemans, F.
    Demanet, C.
    De Waele, M.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 110 - 110
  • [32] The JAK2V617F negative erythrocytosis: A distinctive myeloproliferative syndrome?
    Di Gaetano, R.
    Zanotto, D.
    Belvini, D.
    Salviato, R.
    Pierobon, F.
    De Biasi, E.
    Radossi, P.
    Risato, R.
    Roveroni, G.
    Sartori, R.
    Tassinari, C.
    Toffano, N.
    Tagariello, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 168 - 168
  • [33] Quantification of JAK2V617F mutational burden in chronic myeloproliferative neoplasms
    Alvarez-Larran, Alberto
    MEDICINA CLINICA, 2012, 139 (09): : 393 - 394
  • [34] N-Acetylcysteine As a Therapeutic for JAK2V617F Myeloproliferative Neoplasms
    Craver, Brianna
    Ramanathan, Gajalakshmi
    Luque, Laura Mendez
    Hoang, Summer
    Elalaoui, Kenza
    Brooks, Stefan
    Lai, Hew Yeng
    Fleischman, Angela
    BLOOD, 2018, 132
  • [35] Quantification of JAK2V617F mutation burden by droplet digital PCR in patients with myeloproliferative neoplasms
    Ivanov, H. Y.
    Linev, A.
    Zheliazkov, I.
    Graklanov, V.
    Beleva, E.
    Goranova-Marinova, V.
    Grudeva-Popova, Z.
    Stoyanova, V.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 537 - 538
  • [36] How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?
    Chen, Edwin
    Mullally, Ann
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 268 - 276
  • [37] Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms
    Zhang, Haotian
    Kafeiti, Nicholas
    Masarik, Kyla
    Lee, Sandy
    Yang, Xiaoxi
    Zheng, Haoyi
    Zhan, Huichun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (09) : 1960 - 1974
  • [38] Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
    Yoenal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 174 - 182
  • [39] Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms
    Hu, Linhui
    Pu, Lianfang
    Ding, Yangyang
    Li, Manman
    Cabanero, Michael
    Xie, Jingxin
    Zhou, Dejun
    Yang, Dongdong
    Zhang, Cui
    Wang, Huiping
    Zhai, Zhimin
    Ru, Xiang
    Li, Jingrong
    Xiong, Shudao
    HEMATOLOGY, 2017, 22 (06) : 354 - 360
  • [40] Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
    Ueda, Koki
    Ikeda, Kazuhiko
    Ikezoe, Takayuki
    Harada-Shirado, Kayo
    Ogawa, Kazuei
    Hashimoto, Yuko
    Sano, Takahiro
    Ohkawara, Hiroshi
    Kimura, Satoshi
    Shichishima-Nakamura, Akiko
    Nakamura, Yuichi
    Shikama, Yayoi
    Mori, Tsutomu
    Mason, Philip J.
    Bessler, Monica
    Morishita, Soji
    Komatsu, Norio
    Shide, Kotaro
    Shimoda, Kazuya
    Koide, Shuhei
    Aoyama, Kazumasa
    Oshima, Motohiko
    Iwama, Atsushi
    Takeishi, Yasuchika
    BLOOD ADVANCES, 2017, 1 (15) : 1001 - 1015
12345